Acute myocardial infarction complicated by cardiogenic shock: Role of mechanical circulatory support

Expert Review of Cardiovascular Therapy

Volumn 6, Issue 9, 2008, Pages 1223-1235

  Aggarwal, Sanjeev ^a   Slaughter, Mark S ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

Acute myocardial infarction; Axial flow; Cardiogenic shock; Centrifugal flow; Destination therapy; Heart transplantation; Intra aortic balloon pump; Intracorpeal; Paracorporeal; Percutaneous ventricular assist device; Pulsatile flow; Ventricular assist device

Indexed keywords

ANTICOAGULANT AGENT; FIBRINOLYTIC AGENT; INOTROPIC AGENT;

ACUTE HEART INFARCTION; AORTA BALLOON; ARTIFICIAL VENTILATION; ASSISTED CIRCULATION; BLEEDING; CARDIOGENIC SHOCK; CENTRIFUGAL ANALYZER; CLINICAL TRIAL; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY BYPASS GRAFT; DIASTOLIC BLOOD PRESSURE; EXTRACORPOREAL CIRCULATION; EXTRACORPOREAL OXYGENATION; HEART ASSIST DEVICE; HEART ATRIUM FIBRILLATION; HEART BLOCK; HEART FAILURE; HEART INDEX; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE REVASCULARIZATION; HEART VENTRICLE ARRHYTHMIA; HEMODYNAMICS; HUMAN; INCIDENCE; INFECTION; INTERMETHOD COMPARISON; MORTALITY; OXYGEN SUPPLY; PERCUTANEOUS CORONARY INTERVENTION; PULSATILE FLOW; RESUSCITATION; REVIEW; ST SEGMENT ELEVATION; SURVIVAL; TACHYCARDIA; TREATMENT DURATION;

CLINICAL TRIALS AS TOPIC; HEART-ASSIST DEVICES; HUMANS; INTRA-AORTIC BALLOON PUMPING; MYOCARDIAL INFARCTION; PRACTICE GUIDELINES AS TOPIC; SHOCK, CARDIOGENIC;

EID: 55349110629     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/14779072.6.9.1223     Document Type: Review

References (68)

1. Rosamond W, Flegal K, Furie K et al. Heart disease and stroke statistics - 2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 117(4), E25-E146 (2008).
2. Gheorghiade M, Zannod F, Sopko G et al. Acute heart failure syndromes: current state and framework for future research. Circulation 112, 3958-3968 (2005).
3. American Heart Association. Heart disease and stroke statistics - 2008 Update. American Heart Association, Dallas, TX, USA (2008).
4. Hands ME, Rutherford JD, Muller JE et al. The in-hospital development of cardiogenic shock after myocardial infarction: incidence, predictors of occurrence, outcome and prognostic factors. The MILIS Study Group. J. Am. Coll. Cardiol. 14(1), 40-46; discussion 47-48 (1989).
5. Holmes DR Jr. Cardiogenic shock: a lethal complication of acute myocardial infarction. Rev. Cardiovasc Med. 4(3), 131-135 (2003).
6. White HD, Assmann SF, Sanborn TA et al. Comparison of percutaneous coronary intervention and coronary artery bypass grafting after acute myocardial infarction complicated by cardiogenic shock: results from the Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock (SHOCK) trial. Circulation 112(13), 1992-2001 (2005).
7. Pae WE, Pierce WS. Temporary left ventricular assistance in acute myocardial infarction and cardiogenic shock. Chest 79, 692-695 (1981).
8. Pennington DG, McBride LR, Kanter KR et al. Effect of postoperative myocardial infarction on survival of postcardiotomy patients supported with ventricular-assist devices. Circulation 78(Suppl. 3), 110-115 (1988).
9. Noda H, Takano H, Taenaka Y. Treatment of acute myocardial infarction with cardiogenic shock using left ventricular assist device. Int. J. Artif. Organs 12, 75-79 (1989).
10. Leshnower BG, Gleason TG, O'Hara ML et al. Safety and efficacy of left ventricular assist device support in postmyocardial infarction cardiogenic shock. Ann. Thorac. Surg. 81, 1365-1371 (2006).
11. Hochman JS, Sleeper LA, Webb JG et al. Early revasculariztion in acute myocardial infarction complicated by cardiogenic shock. N. Engl. J. Med. 341, 625-634 (1999).
12. Millane T, Jackson G, Gibbs CR, Lip GYH. ABC of heart failure: acute and chronic management strategies. Br. Med. J. 320, 559-562 (2000).
13. Reynolds HR, Hochman JS. Cardiogenic shock: current concepts and improving outcomes. Circulation 117(5), 686-697 (2008).
14. Menon V, White H, LeJemtel T et al. The clinical profile of patients with suspected cardiogenic shock due to predominant left ventricular failure: a report from the SHOCK Trial Registry. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock? J. Am. Coll. Cardiol. 36 (3 Suppl. A), 1071-1076 (2000).
15. Killip T. Cardiogenic shock complicating myocardial infarction. J. Am. Coll. Cardiol. 14, 47-48 (1989).
16. Allonso D, Scheidt S, Post M, Killip T. Pathophysiology of cardiogenic shock: quantification of myocardial necrosis, clinical, pathologic and electrocardiographic correlations. Circulation 48, 588-596 (1973).
17. Hasdai D, Topol EJ, Califf RM, Berger PB, Holmes DR Jr. Cardiogenic shock complicating acute coronary syndromes. Lancet 356(9231), 749-756 (2000).
18. Webb JG, Sleeper LA, Buller CE et al. Implications of the timing of onset of cardiogenic shock after acute myocardial infarction: a report from the SHOCK Trial Registry. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock? J. Am. Coll. Cardiol. 36(3 Suppl. A), 1084-1090 (2000).
19. Jeger RV, Harkness SM, Ramanathan K et al. Emergency revascularization in patients with cardiogenic shock on admission: a report from the SHOCK trial and registry. Eur. Heart J. 27(6), 664-670 (2006).
20. Antman EM, Hand M, Armstrong PW et al. 2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines: developed in collaboration with the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians: 2007 Writing Group to Review New Evidence and Update the ACC/AHA 2004 Guidelines for the management of patients with ST-elevation myocardial infarction, writing on behalf of the 2004 Writing Committee. Circulation 117(2), 296-329 (2008).
21. Webb JG, Lowe AM, Sanborn TA et al. Percutaneous coronary intervention for cardiogenic shock in the SHOCK trial. J. Am. Coll. Cardiol. 42(8), 1380-1386 (2003).
22. Tayara W, Starling RC, Yamani MH et al. Improved survival after acute myocardial infarction complicated by cardiogenic shock with circulatory support and transplantation: comparing aggressive intervention with conservative treatment. J Heart Lung Transplant. 25 (5), 504-509 (2006).
23. Webb JG, Sanborn TA, Sleeper LA et al. Percutaneous coronary intervention for cardiogenic shock in the SHOCK Trial Registry. Am. Heart J. 141(6), 964-970 (2001).
24. Antman EM, Hand M, Armstrong PW et al. 2007 Focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines. J. Am. Coll. Cardiol. 51(2), 210-247 (2008).
25. Sanborn TA, Sleeper LA, Bates ER et al. Impact of thrombolysis, intra-aortic balloon pump counterpulsation, and their combination in cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock? J Am. Coll. Cardiol. 36(3 Suppl. A), 1123-1129 (2000).
26. Nieminen M, Bohn M, Cowie MR et al. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure. The task force on acute heart failure of the european society of cardiology. Eur. Heart J. 26, 384-416 (2005).
27. Ferguson JJ 3rd, Cohen M, Freedman RJ Jr et al. The current practice of intra-aortic balloon counterpulsation: results from the Benchmark Registry. J. Am. Coll. Cardiol. 38(5), 1456-1462 (2001).
28. Briguori C, Sarais C, Pagnotta P et al. Elective versus provisional intra-aortic balloon pumping in high-risk percutaneous; transluminal coronary angioplasty. Am. Heart J. 145(4), 700-707 (2003).
29. Christenson JT, Simonet F, Badel P, Schmuziger M. The effect of preoperative intra-aortic balloon pump support in patients with coronary artery disease, poor left-ventricular function (LVEF < 40%), and hypertensive LV hypertrophy. Thorac. Cardiovasc. Surg. 45(2), 60-64 (1997).
30. Christenson JT, Simonet F, Badel P, Schmuziger M. Optimal timing of preoperative intraaortic balloon pump support in high-risk coronary patients. Ann. Thorac. Surg. 68(3), 934-939 (1999).
31. Barron HV, Every NR, Parsons LS et al. The use of intra-aortic balloon counterpulsation in patients with cardiogenic shock complicating acute myocardial infarction: data from the National Registry of Myocardial Infarction 2. Am. Heart J. 141(6), 933-939 (2001).
32. Garatti A, Russo C, Lanfranconi M et al. Mechanical circulatory support for cardiogenic shock complicating acute myocardial infarction: an experimental and clinical review. ASAIO J. 53(3), 278-287 (2007).
33. Myers TJ, Khan T, Frazier OH. Infectious complications associated with ventricular assist systems. ASAIO J. 46(6), S28-36 (2000).
34. Pennington DG, Reedy JE, Swartz MT et al. Univentricular versus biventricular assist device support. J Heart Lung Transplant. 10(2), 258-263 (1991).
35. Slaughter MS, Tsui SS, El-Banayosy A et al. Results of a multicenter clinical trial with the Thoratec Implantable Ventricular Assist Device. J. Thorac. Cardiovasc. Surg. 133(6), 1573-1580 (2007).
36. McBride LR, Naunheim KS, Fiore AC, Moroney DA, Swartz MT. Clinical experience with 111 Thoratec ventricular assist devices. Ann. Thorac. Surg. 67(5), 1233-1238; Discussion 1238-1239 (1999).
37. Hendry PJ, Masters RG, Mussivand TV et al. Circulatory support for cardiogenic shock due to acute myocardial infarction: a Canadian experience. Can. J. Cardiol. 15(10), 1090-1094 (1999).
38. Farrar DJ, Holman WR, McBride LR et al. Long-term follow-up of Thoratec ventricular assist device bridge-to-recovery patients successfully removed from support after recovery of ventricular function. J. Heart Lung Transplant. 210), 516-521 (2002).
39. Gray LA Jr, Champsaur GG. The BVS 5000 biventricular assist device. The worldwide registry experience. ASAIO J. 400), M460-M464 (1994).
40. Entwistle JW 3rd, Bolno, PB, Holmes E, Samuels LE. Improved survival with ventricular assist device support in cardiogenic shock after myocardial infarction. Heart Surg. Forum. 6(5), 316-319 (2003).
41. Castells E, Calbet JM, Saura E et al. Acute myocardial infarction with cardiogenic shock: treatment with mechanical circulatory assistance and heart transplantation. Transplant. Proc. 35(5), 1940-1941 (2003).
42. Anderson M, Madani M, Raess D, Samuels L, Sun B. Can ventricular assist devices be considered as part of recovery therapy in acute myocardial infarction cardiogenic shock: a US multicenter study. J. Card. Fail. 12(6), S27 (2006).
43. Anderson MB, Gratz E, Wong RK, Benali K, Kung RT. Improving outcomes in patients with ventricular assist devices transferred from outlying to tertiary care hospitals. J. Extra Corpor. Technol. 39(1), 43-48 (2007).
44. Hill JD, O'Brien TG, Murray JJ et al. Prolonged extracorporeal oxygenation for acute post-traumatic respiratory failure (shock-lung syndrome). Use of the Bramson membrane lung. N. Engl. J. Med. 286(12), 629-634 (1972).
45. Patel H, Pagani FD. Extracorporeal mechanical circulatory assist. Cardiol. Clin. 21(1), 29-41 (2003).
46. Smedira NG, Moazami N, Golding CM et al. Clinical experience with 202 adults receiving extracorporeal membrane oxygenation for cardiac failure: survival at five years. J. Thorac. Cardiovasc. Surg. 122(1), 92-102 (2001).
47. Bartlett RH, Roloff, DW, Custer JR et al. Extracorporeal life support: the University of Michigan experience. JAAM 283, 904-908 (2000).
48. Hsu RB, Chien CY, Wang SS, Chu SH. Survival after early surgical revascularization in patients with both acute myocardial infarction and cardiogenic shock. J. Formos. Med. Assoc. 100(11), 725-728 (2001).
49. Hoefer D, Ruttmann E, Poelzl G et al. Outcome evaluation of the bridge-to-bridge concept in patients with cardiogenic shock. Ann. Thorac. Surg. 82(1), 28-33 (2006).
50. Magovern GJ Jr, Simpson KA. Extracorporeal membrane oxygenation for adult cardiac support: the Allegheny experience. Ann. Thorac. Surg. 68(2), 655-661 (1999).
51. Noon GP, Lafuente JA, Irwin S. Acute and temporary ventricular support with BioMedicus centrifugal pump. Ann. Thorac. Surg. 68(2), 650-654 (1999).
52. Weitkemper HH, El-Banayosy A, Arusoglu L, Sarnowski P, Korfer R. Mechanical circulatory support: reality and dreams experience of a single center. J. Extra Corpor. Technol. 36(2), 169-173 (2004).
53. El-Banayosy A, Posival H, Minami K et al. Seven years of experience with the centrifugal pump in patients with cardiogenic shock. Thorac. Cardiovasc. Surg. 43(6), 347-351 (1995).
54. Shuhaiber JH, Jenkins D, Berman M et al. The Papworth experience with the Levitronix CentriMag ventricular assist device. J Heart Lung Transplant. 27(2), 158-164 (2008).
55. John R. Liao K, Lietz K et al. Experience with the Levitronix CentriMag circulatory support system as a bridge to decision in patients with refractory acute cardiogenic shock and multisystem organ failure. J. Thorac. Cardiovasc. Surg. 134(2),351-358 (2007).
56. Burkhoff D, O'Neill W, Brunckhorst C et al. Feasibility study of the use of the Tandem Heart percutaneous ventricular assist device for treatment of cardiogenic shock. Catheter. Cardiovasc. Interv. 68(2), 211-217 (2006).
57. Loyalka P, Idelchik GM, Kar B. Percutaneous left ventricular assist device complicated by a patent foramen ovate: importance of identification and management. Catheter. Cardiovasc. Interv. 70(3), 383-386 (2007).
58. Aragon J, Lee MS, Kar S, Makkar RR. Percutaneous left ventricular assist device: 'TandemHeart' for high-risk coronary intervention. Catheter. Cardiovasc. Interv. 65(3), 346-352 (2005).
59. Kar B, Forrester M, Gemmato C et al. Use of the TandemHeart percutaneous ventricular assist device to support patients undergoing high-risk percutaneous coronary intervention. J. Invasive Cardiol 18 (4), A6 (2006).
60. Giombolini C, Notaristefano S, Santucci S et al. Percutaneous left ventricular assist device, TandemHeart, for high-risk percutaneous coronary revascularization. A single centre experience. Acute Card. Care 8(1), 35-40 (2006).
61. Burkhoff D, Cohen H, Brunckhorst C, O'Neill WW. A randomized multicenter clinical study to evaluate the safety and efficacy of the TandemHeart percutaneous ventricular assist device versus conventional therapy with intraaortic balloon pumping for treatment of cardiogenic shock. Am. Heart J. 152(3), 469 E461-E468 (2006).
62. Valgimigli M, Steendijk P, Sianos G, Onderwater E, Serruys PW. Left ventricular unloading and concomitant total cardiac output increase by the use of percutaneous Impella Recover LP 2.5 assist device during high-risk coronary intervention. Catheter. Cardiovasc. Interv. 65(2), 263-267 (2005).
63. Meyns B, Dens J, Sergeant P et al. Initial experiences with the Impella device in patients with cardiogenic shock - Impella support for cardiogenic shock. Thorac. Cardiovasc. Surg. 51(6), 312-317 (2003).
64. Meyns B, Stolinski J, Leunens V, Verbeken E, Flameng W. Left ventricular support by catheter- mounted axial flow pump reduces infarct size. J. Am. Coll. Cardiol. 41(7), 1087-1095 (2003).
65. Hugenholtz PG. Acute coronary artery obstruction in myocardial infarction: overview of thrombolytic therapy. J. Am. Coll. Cardiol. 9(6), 1375-1384 (1987).
66. Smalling RW. Transvalvular left ventricular assistance in acute myocardial infarction with cardiogenic shock and high risk angioplasty: experimental and clinical results with the Hemopump. J. Interv. Cardiol. 8(3), 265-273 (1995).
67. Wouters PF, Sukehiro S, Mollhoff T et al. Left ventricular assistance using a catheter-mounted coaxial flow pump (Hemopump) in a canine model of regional myocardial ischaemia. Eur. Heart J. 14(4), 567-575 (1993).
68. Smalling RW, Cassidy DB, Barrett R et al. Improved regional myocardial blood flow, left ventricular unloading, and infarct salvage using an axial-flow, transvalvular left ventricular assist device. A comparison with intra-aortic balloon counterpulsation and reperfusion alone in a canine infarction model. Circulation 85(3), 1152-1159 (1992).